Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Lung cancer, non-small cell
Stage/Subtype:  stage II non-small cell lung cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 38 for your search:
Start Over
Comparing Photon Therapy To Proton Therapy To Treat Patients with Lung Cancer
Phase: Phase III
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: RTOG 1308, NCI-2013-01850, NCT01993810
Erlotinib Hydrochloride in Treating Patients with Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: A081105, NCI-2014-01508, NCT02193282
Crizotinib in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: E4512, NCI-2014-01507, NCT02201992
Indocyanine Green Solution and Near-Infrared Fluorescence Imaging in Lymph Node Mapping in Patients With Stage I-II Non-small Cell Lung Cancer Undergoing Surgery
Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: 05-219, NCI-2012-00260, NCT00264602
A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT)
Phase: Phase II, Phase I
Type: Treatment
Age: Over 18
Trial IDs: 06-0691 / 201012832, NCI-2011-00543, 06-0691, 201012832, NCT00591838
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: M11VOL, NCI-2015-00776, NCT01543672
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 2011-1058, NCI-2012-01224, NCT01629498
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AT13387-05, NCI-2012-02034, 2012-001575-37, NCT01712217
Vaccine Therapy in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 11-094, NCI-2013-00081, NCT01720836
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, P131392, NCT02054104
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 2012-0347, NCI-2012-01249, R01CA026582, NCT01636934
Afatinib Dimaleate in Treating Patients with Stage I-III Non-small Cell Lung Cancer That Was Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-504, NCI-2013-01108, NCT01746251
Combination Chemotherapy and Ipilimumab before Surgery in Treating Patients with Stage IB-III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00038093, NCI-2013-00721, CA184-203, TOP 1201, NCT01820754
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients with Stage II-IV Non-small Cell Lung Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-252, NCI-2014-00216, NCT02073968
Hypofractionated Boost before Chemotherapy and Radiation Therapy in Treating Patients with Stage II or III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14091, NCI-2014-01663, 2014C0112, OSU-14091, NCT02262325
Vaccine Therapy in Treating Patients with Non-small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 08-004, NCI-2014-01874, UPCI 08-004, NCT00793208
Radiation Therapy in Treating Patients with Locally Advanced Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase: Phase I
Type: Treatment
Age: 18 to 80
Trial IDs: RAD2179-12, NCI-2012-01934, NCT01711697
Stereotactic Body Radiation Therapy and Ablation Therapy in Treating Patients With Non-Small Cell Lung Cancer or Lung Metastases
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: INST 1206, NCI-2012-01181, 12-242, NCT01746810
Photodynamic Therapy during Surgery in Treating Patients with Non-small Cell Lung Cancer That Can Be Removed by Surgery
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: I 228112, NCI-2013-00886, NCT01854684
Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients with Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2012-1053, NCI-2013-01357, 9448, NCT01912625
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients with Stage II-III Non-Small Cell Lung Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201404047, NCI-2014-01038, NCT02172846
Start Over